Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
BioDelivery Sciences International, Inc. Announces Pricing of Public Offering of Common Stock
-
BioDelivery Sciences (BDSI) Commences Underwritten Public Offering of Common Stock
-
BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock
-
BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock
-
PolarityTE (PTE) Prices $27.5M Public Offering of Common Stock
-
PolarityTE Announces Pricing of Public Offering of Common Stock
-
PolarityTE (PTE) Announces Proposed Common Share Offering
-
PolarityTE Announces Public Offering of Common Stock
-
Zosano Pharma (ZSAN) Prices Public Offering of Common Stock for Gross Proceeds of $17.5 Million
-
Zosano Announces Pricing of Public Offering of Common Stock
-
UPDATE: Cantor Fitzgerald Starts Ionis Pharmaceuticals (IONS) at Neutral
-
Zosano Pharma (ZSAN) Commences Public Offering of Common Stock
-
Zosano Pharma Announces Proposed Public Offering of Common Stock
-
Theravance Biopharma (TBPH) Looks Cheap Compared To Opportunity - Cantor Fitzgerald
-
Intuitive Surgical (ISRG) Momentum Should Continue - Cantor
-
Cantor Fitzgerald Downgrades Celgene (CELG) to Neutral
-
Rambler Metals & Mining PLC Announces Appointment of CEO
-
Chiasma Announces Closing of $34.5 Million Offering of Common Stock and Full Exercise of Underwriters’ Option
-
UPDATE: Cantor Fitzgerald Starts Verastem (VSTM) at Overweight
-
Horizon Pharma (HZNP) PT Raised to $32 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Benefitfocus (BNFT) at Overweight
-
Cantor Fitzgerald Upgrades McEwen Mining (MUX) to Buy
-
Cantor Fitzgerald Reiterates Overweight Rating on Foamix Pharmaceuticals (FOMX) Amid Finacea Foam Settlement
-
Mylan (MYL) 1Q EPS Estimate Cut At Cantor Fitzgerald, PT Remains $41
-
Zoetis Inc. (ZTS) PT Raised to $116 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating On Merck (MRK) On Keytruda Chinese Conditional Approval
-
Trine Acquisition Corp. Announces Closing of Underwriters’ Over-Allotment Option In Connection With Its Initial Public Offering
-
Trine Acquisition Corp. Announces Closing of Underwriters’ Over-Allotment Option In Connection With Its Initial Public Offering
-
Amarin Corp. (AMRN) Ends Blockbuster Week with a Bang
-
Chiasma, Inc. (CHMA) Prices 6.316M Share Offering at $4.75M
-
Chiasma Announces Pricing of Underwritten Public Offering of $30.0 Million of Common Stock
-
Cantor Fitzgerald Starts TG Therapeutics (TGTX) at Overweight
-
Chiasma, Inc. (CHMA) to Offer Common Stock
-
Chiasma Announces Proposed Offering of Common Stock
-
TAG Associates Announces Bari Goldman Joins Firm as Director of Business Development
-
Theravance Biopharma (TBPH) Poll Highlights Overlooked Market Opportunity - Cantor
-
Amarin Corporation (AMRN) Inclusion In ADA Standards A Significant Positive - Cantor
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Rambler Metals & Mining PLC Announces Posting of Open Offer Circular
-
WellCare Health Plans (WCG) Spread on Pending Deal 'Attractive' - Cantor Fitzgerald
-
Concerns Around CVS Health (CVS) Accelerated PBM Losses Likely Overblown - Cantor Fitzgerald
-
FactSet Research Systems (FDS) PT Raised to $240 at Cantor Fitzgerald
-
Pre-Open Stock Movers 03/26: (ALDX) (BBBY) (BIOC) Higher; (CCL) (MYOK) (RCL) Lower (more...)
-
Aldeyra Therapeutics (ALDX) PT Raised to $35 at Cantor Fitzgerald Following First Successful Pivotal Trial
-
UPDATE: Cantor Fitzgerald Starts Inovio Pharmaceuticals (INO) at Overweight
-
After-Hours Movers 03/25: (LIFE) (INO) Higher; (MYOK) (ZOM) (more...)
-
Proteostasis Therapeutics (PTI) PT Lowered to $14 at Cantor Fitzgerald, Maintains 'Overweight'
-
Cantor Fitzgerald Reiterates Overweight Rating on Dermira (DERM)
-
Cohen & Company and Insurance Acquisition Corp. Announce Completion of Insurance Acquisition Corp. $150,650,000 Initial Public Offering, Including Full Exercise of Over-Allotment Option
-
Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

